SCHEDULE: Freenome Inc. Schedule 13G Filing by Andreessen Horowitz Entities
Beneficial Ownership Filing
Several entities affiliated with Andreessen Horowitz have filed a Schedule 13G, reporting beneficial ownership of Freenome, Inc. common stock.
Summary
- This filing is a Schedule 13G, indicating beneficial ownership of Freenome, Inc. common stock by multiple reporting persons.
- The reporting persons include various AH Bio Fund, AH Equity Partners, Andreessen Horowitz LSV Fund, CLF Partners, and AH Parallel Fund entities, along with Marc L. Andreessen and Benjamin A. Horowitz.
- Collectively, these entities and individuals report beneficial ownership of 5,571,599 shares of Freenome, Inc. common stock.
- This represents approximately 5.2% of the class of securities outstanding as of July 20, 2026.
- The filing clarifies that the reporting persons do not hold these shares for the purpose of influencing or changing the control of Freenome, Inc.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance information.
Positives
- Significant collective ownership stake reported by prominent investors.
- Clear disclosure of beneficial ownership percentages and share counts.
- Filing confirms adherence to regulatory reporting requirements.
Negatives
- No financial performance data or operational updates are included in this filing.
- The filing does not provide insight into the strategic direction or future prospects of Freenome, Inc.
Risks
- Potential for increased scrutiny from regulators due to significant ownership.
- Market perception could be influenced by the collective stake, though no control intent is stated.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Freenome, Inc.'s future performance.
Management Comments
- Marc Andreessen and Benjamin Horowitz have authorized Phil Hathaway as an attorney-in-fact to execute and file reports.
- The reporting persons acknowledge that they are not assuming Freenome, Inc.'s responsibilities to comply with the Act or the Exchange Act.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and venture capital firms like those affiliated with Andreessen Horowitz, indicating significant, but typically passive, stakes in portfolio companies. This filing confirms a substantial collective investment in Freenome, Inc.
Stakeholder Impact
- Shareholders: The filing provides transparency on significant ownership by well-known investors, which may influence market perception.
- Management: Confirms the reporting persons' intent to hold shares without seeking to control the company, providing clarity on their role.
Next Steps
- Continued monitoring of Freenome, Inc. for future disclosures from these reporting persons.
- Potential for future filings if ownership levels change significantly.
Key Dates
| Date | Description |
|---|---|
| 2023-06-22 | Date of Power of Attorney for Benjamin A. Horowitz. |
| 2023-06-23 | Date of Power of Attorney for Marc L. Andreessen. |
| 2026-07-20 | Date of Event Which Requires Filing of this Statement (Schedule 13G filing date). |
| 2026-07-24 | Date of Freenome, Inc.'s Current Report on Form 8-K reporting outstanding shares. |
| 2026-07-27 | Date of signatures on the Schedule 13G and Joint Filing Agreement. |
Keywords
Freenome Inc., Schedule 13G, Beneficial Ownership, Andreessen Horowitz, Marc Andreessen, Benjamin Horowitz, Equity Stake, Securities Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.